Home » All » Stock Forecast » AgomAb Therapeutics NV American Depositary Shares Forecast

AgomAb Therapeutics NV American Depositary Shares Forecasts for Tomorrow, Week, Month and 5 Years

Updated: April 22 · 2026 at 07:03 UTC

From

▲ +1.48%Market Cap $533.67M · Technical analysis Bullish · Focus area Price + volatility

Forecast Summary

Timeframe	Predicted Price	Past	Historical	Insight
Tomorrow	$10.85 ▼ -0.88%	Yesterday	$10.99 ▲ +0.37%	Tomorrow's AgomAb Therapeutics NV American Depositary Shares (AGMB) setup is anchored to $10.95 and targets $10.85 (-0.88%). The near-term read is downside; watch $11.28 / $10.62 because daily realized volatility is about 4.56%.
Tomorrow's AgomAb Therapeutics NV American Depositary Shares (AGMB) setup is anchored to $10.95 and targets $10.85 (-0.88%). The near-term read is downside; watch $11.28 / $10.62 because daily realized volatility is about 4.56%.
Week	$10.65 ▼ -2.75%	Last Week	$11.08 ▲ +1.16%	The 7-day AgomAb Therapeutics NV American Depositary Shares model moves from $11.08 to $10.65 (-2.75%). It gives downside momentum context for this stock, so breaks around $11.28 / $10.62 matter more than a single tick.
The 7-day AgomAb Therapeutics NV American Depositary Shares model moves from $11.08 to $10.65 (-2.75%). It gives downside momentum context for this stock, so breaks around $11.28 / $10.62 matter more than a single tick.
Month	$10.31 ▼ -5.86%	Last Month	$11.22 ▲ +2.46%	The 1-month AgomAb Therapeutics NV American Depositary Shares target is $10.31 (-5.86%), compared with the live reference near $10.95. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
The 1-month AgomAb Therapeutics NV American Depositary Shares target is $10.31 (-5.86%), compared with the live reference near $10.95. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
Year	$9.80 ▼ -10.51%	Last Year	$11.43 ▲ +4.42%	The 1-year AgomAb Therapeutics NV American Depositary Shares scenario points to $9.80 (-10.51%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
The 1-year AgomAb Therapeutics NV American Depositary Shares scenario points to $9.80 (-10.51%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
5 Years	$8.60 ▼ -21.43%	5 Years Ago	$11.94 ▲ +9.00%	The 5-year AgomAb Therapeutics NV American Depositary Shares view is $8.60 (-21.43%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
The 5-year AgomAb Therapeutics NV American Depositary Shares view is $8.60 (-21.43%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

Tomorrow$10.85▼ -0.88%

Yesterday$10.99▲ +0.37%

Tomorrow's AgomAb Therapeutics NV American Depositary Shares (AGMB) setup is anchored to $10.95 and targets $10.85 (-0.88%). The near-term read is downside; watch $11.28 / $10.62 because daily realized volatility is about 4.56%.

Week$10.65▼ -2.75%

Last Week$11.08▲ +1.16%

The 7-day AgomAb Therapeutics NV American Depositary Shares model moves from $11.08 to $10.65 (-2.75%). It gives downside momentum context for this stock, so breaks around $11.28 / $10.62 matter more than a single tick.

Month$10.31▼ -5.86%

Last Month$11.22▲ +2.46%

The 1-month AgomAb Therapeutics NV American Depositary Shares target is $10.31 (-5.86%), compared with the live reference near $10.95. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.

Year$9.80▼ -10.51%

Last Year$11.43▲ +4.42%

The 1-year AgomAb Therapeutics NV American Depositary Shares scenario points to $9.80 (-10.51%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.

5 Years$8.60▼ -21.43%

5 Years Ago$11.94▲ +9.00%

The 5-year AgomAb Therapeutics NV American Depositary Shares view is $8.60 (-21.43%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

Risk notice:This forecast is informational only, not financial advice; accuracy depends on volatility, liquidity, macro events, and other external factors.

Price Chart

HistoricalForecastBullishBearish

Technical Analysis

Neutral

Bullish

Neutral

Bearish

Key Indicators

Indicator	Value	Signal
Price	$10.95	Mid
Daily Change	+1.48%	Above
Volatility Cap	20.0%	Mid
Confidence	60%	Below
Data Source	nasdaq-screener	Mid

Historical Data

Current$10.95

Daily Change+1.48%

Market Cap$533.67M

Sourcenasdaq-screener

Current	$10.95	Daily Change	+1.48%
Market Cap	$533.67M	Source	nasdaq-screener

Support & Resistance Levels

$10.62Support 1

$10.95Current

$11.28Resistance 1

Support and resistance are estimated from the trusted current price until deeper historical data is available.

Price Milestones

Key levels & historical context

Current$10.95Live reference price

Used as the anchor for generated forecast calculations.

Next Month$10.31Model projection-5.86%

Directional scenario based on capped drift.

Forecast Accuracy

How our model has performed

60%

Directional

Generated market-data forecast

This page uses live catalog market data and conservative volatility caps. It is informational, not financial advice.

📊

Our algorithm is re-calibrated weekly using the latest price action, volatility regime, and indicator signals. Accuracy varies by timeframe — short-term momentum is more reliable than long-term projections.

Short term

60%

Direction confidence

Long term

Lower

Forecast uncertainty rises with horizon

Investment Scenarios

If you invest $1,000 in AGMB today

Bullish Scenario

$11.50

+5.00% from current

Target Price$11.50

ScenarioUpside momentum

Probability52%

Base Scenario

$10.31

-5.86%

Target Price$10.31

ScenarioCapped drift

Probability60%

Bearish Scenario

$10.40

-5.00% from current

Target Price$10.40

ScenarioVolatility drawdown

Probability40%

Basis: Scenario model combines current spot price, recent market direction, and conservative asset-class volatility caps.

Forecast Factors

Market Structure

Price structure reflects the latest momentum regime and support/resistance interaction.

Momentum Bearish · 38/100

24H drift-0.88%

7D drift-2.75%

30D drift-5.86%

Technical Signals

Signals combine RSI, MACD, and moving average stacks to estimate short-term direction.

Mixed — Watching · 50/100

RSIn/a

MACDn/a

MA stackn/a

Macro Context

Rates, dollar strength, and cross-asset risk appetite influence medium-term paths.

Risk-Off Caution · 31/100

1M outlook-5.86%

1Y outlook-10.51%

5Y outlook-21.43%

Frequently Asked Questions

Q What is the AgomAb Therapeutics NV American Depositary Shares (AGMB) forecast for tomorrow?

Using the latest BeCoin market snapshot (April 22 · 2026 at 07:03 UTC), AgomAb Therapeutics NV American Depositary Shares is projected near $10.85 versus the current reference around $10.95. That implies a modeled move of -0.88% over the next day, with realized prices still sensitive to intraday volatility.

Q What does the 7-day stock outlook suggest for AGMB?

The weekly AgomAb Therapeutics NV American Depositary Shares model points to $10.65, which maps to an expected drift of -2.75% from current conditions. This horizon reacts quickly to momentum shifts, so support/resistance breaks can change the path faster than long-term targets.

Q How should I read the AgomAb Therapeutics NV American Depositary Shares 1-month and 1-year targets?

The AgomAb Therapeutics NV American Depositary Shares 1-month target is $10.31 (-5.86%), while the 1-year target is $9.80 (-10.51%). The monthly view tracks prevailing trend pressure, and the yearly view reflects broader cycle assumptions shaped by price momentum, liquidity, and company-specific risk.

Q Why does the AgomAb Therapeutics NV American Depositary Shares 5-year scenario differ from short-term rows?

The AgomAb Therapeutics NV American Depositary Shares long-horizon scenario sits near $8.60 with a modeled change of -21.43%. It compounds cycle-continuation assumptions over time, so it should be treated as a scenario envelope rather than a precise endpoint.

Q Where are AGMB support and resistance zones right now?

For AgomAb Therapeutics NV American Depositary Shares, nearest resistance is around $10.62, while nearest support is around $11.28. A clean break above resistance improves continuation odds, while repeated closes under support raise downside risk.

Q How fresh is the AgomAb Therapeutics NV American Depositary Shares market snapshot?

The displayed stock snapshot is labeled April 22 · 2026 at 07:03 UTC; the latest observed session range is roughly n/a to n/a. These checkpoints are rebuilt from the market feed so the FAQ, milestones, and support/resistance context stay tied to the same data refresh.